Inovio Pharmaceuticals Inc (NASDAQ:INO)

8.26
Delayed Data
As of May 21
 +0.05 / +0.61%
Today’s Change
6.33
Today|||52-Week Range
14.20
-10.02%
Year-to-Date

Today’s Trading

Previous close8.21
Today’s open8.34
Day’s range-- - --
Volume498,958
Average volume (3 months)1,228,010
Market cap$589.6M
Dividend yield--
Data as of 05/21/2015

Growth & Valuation

Earnings growth (last year)+55.56%
Earnings growth (this year)+0.31%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-22.35%
P/E ratioNM
Price/Sales51.91
Price/Book4.48

Competitors

 Today’s
change
Today’s
% change
XENTIntersect ENT Inc-1.31-5.34%
ANGOAngioDynamics Inc-0.22-1.36%
BLCMBellicum Pharmaceuti...+0.42+1.79%
OCULOcular Therapeutix I...-0.28-1.10%
Data as of 05/21/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$10.5M
Annual profit (last year)-$36.1M
Net profit margin-345.44%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
J. Joseph Kim
Chief Operating Officer
Niranjan Y. Sardesai
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers